These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 24161452)

  • 1. C-reactive protein and cortisol in drug-naïve patients with short-illness-duration first episode major depressive disorder: possible role of cortisol immunomodulatory action at early stage of the disease.
    Cubała WJ; Landowski J
    J Affect Disord; 2014 Jan; 152-154():534-7. PubMed ID: 24161452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnesium, C-reactive protein, and cortisol in drug-naïve patients with short illness-duration, first episode major depressive disorder: possible immunomodulatory role for magnesium.
    Cubała WJ; Landowski J; Dziadziuszko M; Chrzanowska A; Wielgomas B
    Magnes Res; 2016 Apr; 29(4):169-174. PubMed ID: 27965189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low baseline salivary alpha-amylase in drug-naïve patients with short-illness-duration first episode major depressive disorder.
    Cubała WJ; Landowski J
    J Affect Disord; 2014 Mar; 157():14-7. PubMed ID: 24581822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low baseline salivary 3-methoxy-4-hydroxyphenylglycol (MHPG) in drug-naïve patients with short-illness-duration first episode major depressive disorder.
    Cubała WJ; Landowski J; Wielgomas B; Czarnowski W
    J Affect Disord; 2014 Jun; 161():4-7. PubMed ID: 24751300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin response to buspirone is not impaired in drug-naïve first episode patients with major depressive disorder.
    Cubała WJ; Landowski J
    J Affect Disord; 2014 Jan; 152-154():468-73. PubMed ID: 24035672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RELATIONSHIP BETWEEN THE CORTICAL THICKNESS AND SERUM CORTISOL LEVELS IN DRUG-NAÏVE, FIRST-EPISODE PATIENTS WITH MAJOR DEPRESSIVE DISORDER: A SURFACE-BASED MORPHOMETRIC STUDY.
    Liu X; Kakeda S; Watanabe K; Yoshimura R; Abe O; Ide S; Hayashi K; Katsuki A; Umeno-Nakano W; Watanabe R; Ueda I; Moriya J; Nakamura J; Korogi Y
    Depress Anxiety; 2015 Sep; 32(9):702-8. PubMed ID: 26290363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salivary 5-hydroxyindole acetic acid (5-HIAA) in drug-naïve patients with short-illness-duration first episode major depressive disorder.
    Cubala WJ; Landowski J; Chrzanowska A
    Neuro Endocrinol Lett; 2014; 35(8):746-9. PubMed ID: 25702305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnesium in drug-naïve patients with a short-duration, first episode of major depressive disorder: impact on psychopathological features.
    Cubała WJ; Landowski J; Szyszko M; Czarnowski W
    Magnes Res; 2013; 26(4):192-8. PubMed ID: 24509052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study.
    Vreeburg SA; Hoogendijk WJ; van Pelt J; Derijk RH; Verhagen JC; van Dyck R; Smit JH; Zitman FG; Penninx BW
    Arch Gen Psychiatry; 2009 Jun; 66(6):617-26. PubMed ID: 19487626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zinc in drug-naïve patients with short-illness-duration first episode major depressive disorder: impact on psychopathological features.
    Cubala WJ; Landowski J; Szyszko M; Wielgomas B
    Neuro Endocrinol Lett; 2014; 35(8):741-5. PubMed ID: 25702304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ghrelin and depressive symptoms in patients with first-episode drug-naïve major depressive disorder: The mediating role of hypothalamic-pituitary-adrenal axis.
    Zhang C; Dong Y; Li S; Li M; Gao Y; Liu Y; Liu X; Zhou C; Li J
    Asia Pac Psychiatry; 2024 Mar; 16(1):e12552. PubMed ID: 38348641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive functioning and cortisol profiles in first episode major depression.
    Hansson PB; Murison R; Lund A; Hammar Å
    Scand J Psychol; 2015 Aug; 56(4):379-83. PubMed ID: 26032571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hair cortisol as a marker of hypothalamic-pituitary-adrenal Axis activity in female patients with major depressive disorder.
    Pochigaeva K; Druzhkova T; Yakovlev A; Onufriev M; Grishkina M; Chepelev A; Guekht A; Gulyaeva N
    Metab Brain Dis; 2017 Apr; 32(2):577-583. PubMed ID: 28064407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salivary alpha-amylase and cortisol responsiveness following electrical stimulation stress in major depressive disorder patients.
    Tanaka Y; Ishitobi Y; Maruyama Y; Kawano A; Ando T; Okamoto S; Kanehisa M; Higuma H; Ninomiya T; Tsuru J; Hanada H; Kodama K; Isogawa K; Akiyoshi J
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Mar; 36(2):220-4. PubMed ID: 22063648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal hypothalamic-pituitary-adrenal axis trait and state effects in recurrent depression.
    Lok A; Mocking RJ; Ruhé HG; Visser I; Koeter MW; Assies J; Bockting CL; Olff M; Schene AH
    Psychoneuroendocrinology; 2012 Jul; 37(7):892-902. PubMed ID: 22094110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortisol response patterns in depressed women and their healthy daughters at risk: Comparison with healthy women and their daughters.
    Gonul AS; Cetinkalp S; Tunay S; Polat I; Simsek F; Aksoy B; Kizilates G; Erdogan Y; Coburn KL
    J Psychiatr Res; 2017 Feb; 85():66-74. PubMed ID: 27837659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-reactive protein: A differential biomarker for major depressive disorder and bipolar II disorder.
    Chang HH; Wang TY; Lee IH; Lee SY; Chen KC; Huang SY; Yang YK; Lu RB; Chen PS
    World J Biol Psychiatry; 2017 Feb; 18(1):63-70. PubMed ID: 26895280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender differences in serum testosterone and cortisol in patients with major depressive disorder compared with controls.
    Matsuzaka H; Maeshima H; Kida S; Kurita H; Shimano T; Nakano Y; Baba H; Suzuki T; Arai H
    Int J Psychiatry Med; 2013; 46(2):203-21. PubMed ID: 24552043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum concentrations of CRP, IL-6, TNF-α and cortisol in major depressive disorder with melancholic or atypical features.
    Karlović D; Serretti A; Vrkić N; Martinac M; Marčinko D
    Psychiatry Res; 2012 Jun; 198(1):74-80. PubMed ID: 22386567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between the hypothalamic pituitary adrenal axis and tryptophan metabolism in persons with recurrent major depressive disorder and healthy controls.
    Sorgdrager FJH; Doornbos B; Penninx BWJH; de Jonge P; Kema IP
    J Affect Disord; 2017 Nov; 222():32-39. PubMed ID: 28668713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.